NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 4MVJ designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
4MVJ_NAD_C_401 | 16% | 35% | 0.273 | 0.843 | 1.39 | 1.28 | 6 | 6 | 4 | 0 | 100% | 1 |
4MVJ_NAD_P_401 | 13% | 39% | 0.336 | 0.879 | 1.08 | 1.38 | 3 | 6 | 2 | 0 | 100% | 0.5 |
4MVJ_NAD_D_401 | 11% | 38% | 0.344 | 0.86 | 1.02 | 1.46 | 3 | 10 | 3 | 0 | 100% | 0.5 |
4MVJ_NAD_I_401 | 9% | 44% | 0.388 | 0.882 | 1.05 | 1.14 | 4 | 4 | 0 | 0 | 100% | 0.5 |
4MVJ_NAD_O_401 | 8% | 40% | 0.366 | 0.848 | 0.85 | 1.56 | 2 | 7 | 4 | 0 | 100% | 0.5 |
4MVJ_NAD_K_401 | 8% | 37% | 0.343 | 0.824 | 1.1 | 1.43 | 4 | 8 | 5 | 0 | 100% | 0.5 |
4MVJ_NAD_E_401 | 6% | 35% | 0.433 | 0.869 | 0.96 | 1.66 | 2 | 9 | 0 | 0 | 100% | 0.5 |
2VYN_NAD_D_1341 | 97% | 28% | 0.064 | 0.98 | 1.69 | 1.32 | 4 | 3 | 1 | 0 | 100% | 1 |
1DC6_NAD_B_352 | 78% | 13% | 0.112 | 0.956 | 2.18 | 1.93 | 7 | 9 | 2 | 0 | 100% | 1 |
2VYV_NAD_D_1340 | 55% | 28% | 0.145 | 0.915 | 1.82 | 1.23 | 4 | 1 | 3 | 0 | 100% | 1 |
4URF_NAD_A_1249 | 100% | 45% | 0.034 | 0.995 | 0.96 | 1.2 | 2 | 4 | 0 | 0 | 100% | 1 |
2C5A_NAD_B_1374 | 100% | 25% | 0.039 | 0.992 | 1.34 | 1.84 | 6 | 7 | 1 | 0 | 100% | 1 |
1HET_NAD_A_402 | 100% | 11% | 0.043 | 0.994 | 2.25 | 2.1 | 9 | 8 | 0 | 0 | 100% | 0.9068 |
2JHF_NAD_B_403 | 100% | 18% | 0.04 | 0.99 | 2.08 | 1.62 | 11 | 5 | 2 | 0 | 100% | 1 |
1HEU_NAD_B_402 | 100% | 8% | 0.043 | 0.993 | 2.5 | 2.41 | 13 | 11 | 0 | 0 | 100% | 0.8886 |